SEC Form 4 · accession 0000885590-15-000074
Bausch Health Companies Inc. · BHC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert L. Rosiello
Officer — EVP, Chief Financial Officer
Period of report
Oct 20, 2015
Accepted (ET)
Oct 22, 2015 · 5:01 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000885590
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Restricted Share UnitsF1,F2 | Oct 20, 2015 | A | 7,875 | $0.00 | A | 449,550 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents Restricted Share Units received under an Employee Share Matching Program ("Matching RSUs") in connection with the officer's purchase of Company common stock. Each Matching RSU represents a contingent right to receive one share of common stock, no par value, of Valeant Pharmaceuticals International, Inc.
- F21/5 of the Matching RSUs will vest each on the first, second, third, fourth and fifth anniversary of the date of grant subject to continued employment and retention of the corresponding purchased shares.